AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Synovics Pharmaceuticals, Inc.

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0 - $0
Market Cap
2.98K
AVG Volume
299
Trailing/Forward PE
-0/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
02M4M6M8M07 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q109 Q209 Q3
SYVC Revenue (USD) by quarter
PeriodRevenue (USD)
09 Q31.58M
09 Q22.81M
09 Q16.84M
08 Q47.87M
08 Q37.72M
08 Q26.12M
08 Q14.26M
07 Q45.33M
07 Q36.88M
07 Q25.71M
Net Income (USD)
-7.5M-5M-2.5M02.5M07 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q109 Q209 Q3
SYVC Net Income (USD) by quarter
PeriodNet Income (USD)
09 Q3-2.02M
09 Q2-2.59M
09 Q1-1.1M
08 Q4670.33K
08 Q3489.67K
08 Q2-2.94M
08 Q1-2.22M
07 Q4-4.23M
07 Q3-7.49M
07 Q2-6.77M
Operating Income (USD)
-6M-4M-2M02M07 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q109 Q209 Q3
SYVC Operating Income (USD) by quarter
PeriodOperating Income (USD)
09 Q3-1.86M
09 Q2-2.09M
09 Q1-633.82K
08 Q4265.52K
08 Q3-770.73K
08 Q2-987.32K
08 Q1-990.94K
07 Q4-2.48M
07 Q3-2.19M
07 Q2-5.15M
EBITDA (USD)
-6M-4M-2M02M4M07 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q109 Q209 Q3
SYVC EBITDA (USD) by quarter
PeriodEBITDA (USD)
09 Q3-1.64M
09 Q2-1.96M
09 Q1-478.45K
08 Q4265.52K
08 Q32.24M
08 Q2-987.32K
08 Q1-482.85K
07 Q4-2.48M
07 Q3-241.99K
07 Q2-5.15M
Cash Flows (USD)
-4M-2M02M4M07 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q109 Q209 Q3
SYVC Cash Flows (USD) by quarter
PeriodCash Flows (USD)
09 Q317.62K
09 Q289.86K
09 Q1543.62K
08 Q41.12M
08 Q32.12M
08 Q2-764.86K
08 Q1679.36K
07 Q4-1.49M
07 Q3-2.86M
07 Q20
EPS (USD)
-0.3-0.2-0.1-00.107 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q109 Q209 Q3
SYVC EPS (USD) by quarter
PeriodEPS (USD)
09 Q3-0.07
09 Q2-0.09
09 Q1-0.04
08 Q40.03
08 Q30.01
08 Q2-0.14
08 Q1-0.12
07 Q4-0.22
07 Q3-0.25
07 Q2-0.23
Expenses (USD)
02M4M6M8MR&DSG&ACapex07 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q109 Q209 Q3
SYVC Expenses (USD) by quarter
PeriodExpenses (USD)
09 Q31.32M
09 Q22.12M
09 Q13.02M
08 Q42.53M
08 Q34.1M
08 Q23.41M
08 Q12.12M
07 Q43.45M
07 Q35.43M
07 Q27.25M
Cash & Debt (USD)
010M20M30MCashLong Term DebtShort Term Debt07 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q109 Q209 Q3
SYVC Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
09 Q3129.86K
09 Q29.28K
09 Q119.62K
08 Q465.99K
08 Q3426.06K
08 Q221.9K
08 Q11K
07 Q40
07 Q32.55M
07 Q22.98M
Debt ratios
-25025507510007 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q109 Q209 Q3
SYVC Debt ratios by quarter
PeriodDebt ratios
09 Q3-1.16
09 Q289.93
09 Q15.48
08 Q46.29
08 Q3-4.84
08 Q2-4.49
08 Q1-2.18
07 Q4-2.33
07 Q3-2.63
07 Q2-2.52
Margins
-40%-20%0%20%40%07 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q109 Q209 Q3
SYVC Margins by quarter
PeriodMargins
09 Q3-36.73%
09 Q20.99%
09 Q134.25%
08 Q434.01%
08 Q338.97%
08 Q237.51%
08 Q123.32%
07 Q418.2%
07 Q337.57%
07 Q227.87%
Return on Capital
-200%0%200%400%07 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q109 Q209 Q3
SYVC Return on Capital by quarter
PeriodReturn on Capital
09 Q3261.42%
09 Q2-193.5%
09 Q1-27.27%
08 Q413.4%
08 Q312.29%
08 Q227.61%
08 Q121.54%
07 Q452.17%
07 Q3170.07%
07 Q2-57.94%
Shares Outstanding
010M20M30M07 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q109 Q209 Q3
SYVC Shares Outstanding by quarter
PeriodShares Outstanding
09 Q329.89M
09 Q228.66M
09 Q128.34M
08 Q425.95M
08 Q328.48M
08 Q221.1M
08 Q119.12M
07 Q419.09M
07 Q329.66M
07 Q229.92M
Book Value Per Share (USD)
-0.75-0.5-0.2500.250.507 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q109 Q209 Q3
SYVC Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
09 Q3-0.03
09 Q20.05
09 Q10.14
08 Q40.19
08 Q30.14
08 Q2-0.5
08 Q1-0.54
07 Q4-0.42
07 Q3-0.15
07 Q20.39
Total Assets (USD)
020M40M60M07 Q207 Q307 Q408 Q108 Q208 Q308 Q409 Q109 Q209 Q3
SYVC Total Assets (USD) by quarter
PeriodTotal Assets (USD)
09 Q318.77M
09 Q219.43M
09 Q121.78M
08 Q422.35M
08 Q323.58M
08 Q223.93M
08 Q121.22M
07 Q423.33M
07 Q327.93M
07 Q242.11M
Free Cash Flow Yield
59370.9%59370.9%59370.9%59370.9%59370.9%med 59370.9%Jan 25May 25Sep 25Jan 26May 26Sep 26
SYVC Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 2659370.9%
Sep 2659370.9%
Aug 2659370.9%
Aug 2659370.9%
Aug 2659370.9%
Aug 2659370.9%
Jul 2659370.9%
Jul 2659370.9%
Jul 2659370.9%
Jul 2659370.9%
Jul 2659370.9%
Jun 2659370.9%
Jun 2659370.9%
Jun 2659370.9%
Jun 2659370.9%
May 2659370.9%
May 2659370.9%
May 2659370.9%
May 2659370.9%
May 2659370.9%
Apr 2659370.9%
Apr 2659370.9%
Apr 2659370.9%
Apr 2659370.9%
Mar 2659370.9%
Mar 2659370.9%
Mar 2659370.9%
Mar 2659370.9%
Feb 2659370.9%
Feb 2659370.9%
Feb 2659370.9%
Feb 2659370.9%
Jan 2659370.9%
Jan 2659370.9%
Jan 2659370.9%
Jan 2659370.9%
Jan 2659370.9%
Dec 2559370.9%
Dec 2559370.9%
Dec 2559370.9%
Dec 2559370.9%
Nov 2559370.9%
Nov 2559370.9%
Nov 2559370.9%
Nov 2559370.9%
Oct 2559370.9%
Oct 2559370.9%
Oct 2559370.9%
Oct 2559370.9%
Oct 2559370.9%
Sep 2559370.9%
Sep 2559370.9%
Sep 2559370.9%
Sep 2559370.9%
Aug 2559370.9%
Aug 2559370.9%
Aug 2559370.9%
Aug 2559370.9%
Aug 2559370.9%
Jul 2559370.9%
Jul 2559370.9%
Jul 2559370.9%
Jul 2559370.9%
Jun 2559370.9%
Jun 2559370.9%
Jun 2559370.9%
Jun 2559370.9%
May 2559370.9%
May 2559370.9%
May 2559370.9%
May 2559370.9%
May 2559370.9%
Apr 2559370.9%
Apr 2559370.9%
Apr 2559370.9%
Apr 2559370.9%
Mar 2559370.9%
Mar 2559370.9%
Mar 2559370.9%
Mar 2559370.9%
Feb 2559370.9%
Feb 2559370.9%
Feb 2559370.9%
Feb 2559370.9%
Jan 2559370.9%
Jan 2559370.9%
Jan 2559370.9%
Jan 2559370.9%
Jan 2559370.9%
Dec 2459370.9%
Dec 2459370.9%
Dec 2459370.9%
Dec 2459370.9%
Nov 2459370.9%
Nov 2459370.9%
Nov 2459370.9%
Nov 2459370.9%
Nov 2459370.9%
Oct 2459370.9%
Oct 2459370.9%
Price to Sales
00000med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SYVC Price to Sales by quarter
PeriodPrice to Sales
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Nov 240
Nov 240
Oct 240
Oct 240
EV/EBITDA
050100150med 12.05Feb 09Mar 09May 09Jun 09Jul 09Sep 09Oct 09
SYVC EV/EBITDA by quarter
PeriodEV/EBITDA
Oct 09114.99
Oct 09112.71
Oct 09112.71
Oct 09112.71
Sep 09112.71
Sep 09112.71
Sep 09110.44
Sep 09108.16
Aug 09108.16
Aug 09107.7
Aug 09108.16
Aug 09108.16
Jul 09113.17
Jul 096.88
Jul 096.88
Jul 096.88
Jul 097.23
Jun 098.77
Jun 097.94
Jun 099.31
Jun 0911.5
May 0912.33
May 099.04
May 0912.05
May 0912.05
May 0912.05
Apr 0912.34
Apr 0912.59
Apr 0911.83
Apr 099.82
Mar 099.82
Mar 099.82
Mar 099.82
Mar 099.82
Feb 099.82
Feb 0911.08
Feb 0913.59
Feb 0912.34
Jan 0912.34
Price/Operating Cashflow
0000med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SYVC Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Nov 240
Nov 240
Oct 240
Oct 240
Price to Book
01234med 2.01Feb 07May 07Aug 07Dec 08Mar 09Jul 09Oct 09
SYVC Price to Book by quarter
PeriodPrice to Book
Oct 091.18
Oct 091.07
Oct 091.07
Oct 091.07
Sep 091.07
Sep 091.07
Sep 090.96
Sep 090.86
Aug 090.86
Aug 090.83
Aug 090.86
Aug 090.86
Jul 091.09
Jul 090.36
Jul 090.36
Jul 090.36
Jul 090.45
Jun 090.84
Jun 090.63
Jun 090.98
Jun 091.54
May 091.75
May 090.91
May 091.68
May 091.68
May 091.68
Apr 091.25
Apr 091.3
Apr 091.14
Apr 090.73
Mar 090.73
Mar 090.73
Mar 090.73
Mar 090.73
Feb 090.73
Feb 090.99
Feb 091.5
Feb 091.25
Jan 091.25
Jan 091.64
Jan 091.64
Jan 091.64
Jan 091.64
Dec 081.64
Dec 081.64
Dec 082.5
Dec 082.5
Nov 082.5
Nov 082.5
Nov 082.5
Nov 082.5
Oct 082.5
Oct 071.97
Oct 072.25
Oct 072.3
Oct 072.18
Sep 072.28
Sep 072.18
Sep 072.05
Sep 071.92
Aug 071.69
Aug 071.68
Aug 071.92
Aug 072.43
Aug 072.38
Jul 072.31
Jul 072.52
Jul 072.7
Jul 072.4
Jun 072.29
Jun 072.13
Jun 072.29
Jun 072.52
Jun 072.52
May 072.4
May 072.86
May 073.43
May 073.43
Apr 073.17
Apr 072.66
Apr 072.86
Apr 072.76
Mar 072.56
Mar 072.76
Mar 072.35
Mar 072.07
Mar 072.45
Feb 072.56
Feb 072.86
Feb 072.97
Feb 073.07
Jan 072.24
Jan 072.46
Jan 072.61
Jan 072.54
Dec 062.55
Dec 062.54
Dec 062.39
Dec 062.76
Dec 062.76
Synovics Pharmaceuticals, Inc.
SYVC
Stockpicker

Video analysis: SYVC

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.